These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 28182861

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diffuse Pulmonary Ossification on High-Resolution Computed Tomography in Idiopathic Pulmonary Fibrosis, Systemic Sclerosis-Related Interstitial Lung Disease, and Chronic Hypersensitivity Pneumonitis: A Comparative Study.
    Walkoff L, Dixit AS, Ryu JH, Chung JH, Cox CW.
    J Comput Assist Tomogr; 2020; 44(5):667-672. PubMed ID: 32842066
    [Abstract] [Full Text] [Related]

  • 3. Idiopathic dendriform pulmonary ossification as the phenotype of interstitial lung abnormalities: CT-pathologic correlation and prevalence.
    Ueno M, Egashira R, Hashisako M, Fujimoto K, Fukuda T, Hayashida Y, Sumikawa H, Tominaga J, Tanaka T, Terasaki Y, Fukuoka J, Nishioka Y, Aoki T, Gabata T, Hatabu H, Johkoh T.
    Jpn J Radiol; 2024 Sep; 42(9):993-1002. PubMed ID: 38740642
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia.
    Yoshimura K, Kono M, Enomoto Y, Nishimoto K, Oyama Y, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Sumikawa H, Johkoh T, Colby TV, Sugimura H, Suda T.
    Respir Med; 2018 Apr; 137():167-175. PubMed ID: 29605201
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
    Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, Nicholson AG, Colby TV, Denton CP, Black CM, du Bois RM, Wells AU.
    Radiology; 2004 Aug; 232(2):560-7. PubMed ID: 15286324
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
    Olson AL, Patnaik P, Hartmann N, Bohn RL, Garry EM, Wallace L.
    Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606
    [Abstract] [Full Text] [Related]

  • 12. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
    Traila D, Oancea C, Tudorache E, Mladinescu OF, Timar B, Tudorache V.
    J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
    [Abstract] [Full Text] [Related]

  • 13. Air trapping in usual interstitial pneumonia pattern at CT: prevalence and prognosis.
    Hochhegger B, Sanches FD, Altmayer SPL, Pacini GS, Zanon M, Guedes ÁDCB, Watte G, Meirelles G, Barros MC, Marchiori E, Rubin AS.
    Sci Rep; 2018 Nov 22; 8(1):17267. PubMed ID: 30467322
    [Abstract] [Full Text] [Related]

  • 14. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL, Maher TM, Acciai V, Mounir B, Quaresma M, Zouad-Lejour L, Wells CD, De Loureiro L.
    Adv Ther; 2020 Jul 22; 37(7):3292-3298. PubMed ID: 32451950
    [Abstract] [Full Text] [Related]

  • 15. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M, INBUILD trial investigators.
    Lancet Respir Med; 2020 May 22; 8(5):453-460. PubMed ID: 32145830
    [Abstract] [Full Text] [Related]

  • 16. A quantitative analysis of progressive fibrosing interstitial lung disease on computed tomography for the assessment of decreased vital capacity.
    Kunihiro Y, Matsumoto T, Onoda H, Murakami T, Iduki M, Hirano Y, Ito K.
    Acta Radiol; 2024 Aug 22; 65(8):922-929. PubMed ID: 38747886
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevalence and prognosis of unclassifiable interstitial lung disease.
    Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE, Wolters PJ, Collard HR.
    Eur Respir J; 2013 Sep 22; 42(3):750-7. PubMed ID: 23222877
    [Abstract] [Full Text] [Related]

  • 20. Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease.
    Hwang JH, Misumi S, Sahin H, Brown KK, Newell JD, Lynch DA.
    J Comput Assist Tomogr; 2009 Sep 22; 33(3):410-5. PubMed ID: 19478636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.